Our research shows that with the prolongation of the course of disease, the risk of DKD diagnosis in T2DM patients will increase, but the content of cystatin C in the human body does not increase with the prolongation of the disease course. This evidence concerns the gene CST3 and type 2 diabetes mellitus.